See our new publication in Nature Comm that shows for the first time the effect of a catalytic site inhibitor of IDE in vivo:
Deprez-Poulain, R., et al Nature Comm.,2015, 6. doi:10.1038/ncomms9250 OPEN ACCESS
Deprez'lab Drugs & Molecules for Living Systems
Our laboratory's mission is to design and study compounds that modulates selected molecular targets in a desired way to treat infectious and metabolic diseases. Our projects engage researchers across physical, chemical and biological sciences to trade ideas and knowledge and sincerely endeavor to validate new therapeutic concepts with drug prototypes and bring drugs candidates to the clinic.
For more information visit our website